Protection by minigenes: A novel approach of DNA vaccines

Vaccine

Volumn 16, Issue 17, 1998, Pages 1660-1667

  Yu, Zhiya ^a   Karem, Kevin L ^b   Kanangat, Sivadesan ^c   Manickan, Elanchezhiyan ^d   Rouse, Barry T ^e  

^a MAYO CLINIC   (United States)

^b Heska Corp and Centers for Dis C   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NONE

Author keywords

DNA vaccine; Epitope; HSV

Indexed keywords

CYTOKINE; DNA VACCINE; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; PLASMID DNA; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENETIC ENGINEERING; HELPER CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, VIRAL; FEMALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SIMPLEXVIRUS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL VACCINES;

EID: 0032192631     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00065-6     Document Type: Article

References (21)

1. 1 Miller, M.A., Leggatt, G.R. and Berzofsky, J.A. Selective expansion of high-or low avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl Acad. Sci. USA 1996, 93, 4102-4107.
2. 2 Banks, T.A., Nair, S. and Rouse, B.T. Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus. J. Virol. 1993, 67, 613-616.
3. 3 Ciernik, I.F., Berzofsky, J.A. and Carbone, F.P. Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes. J. Immunol. 1996, 156, 2369-2375.
4. 4 Donnelly, J.J., Ulmer, J.B., Shiver, J.W. and Liu, M.A. DNA vaccines. Annu. Rev. Immunol. 1997, 15, 617-648.
5. 5 Francis, M.J. Peptide vaccines for viral diseases. Sci. Prog. 1990, 74, 115-130.
6. 6 Fynan, E.F., Webster, R.G., Fuller, D.H., Haynes, J.R., Santoro, J.C. and Robinson, H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl Acad. Sci. USA 1993, 90, 11478-11482.
7. 7 Geerligs, H.J., Kocken, C.H. and Drijfhout, J.W. et al. Virus neutralizing activity induced by synthetic peptides of glycoprotein D of herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from mice. J. Gen. Virol. 1990, 71, 1767-1774.
8. 8 Hanke, T., Graham, F.L., Rosenthal, K.L. and Johnson, D.C. Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides. J. Virol. 1991, 65, 1177-1186.
9. 9 Haynes, B.F., Torres, J.V. and Langlois, A.J. et al. Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides. J. Immunol. 1993, 151, 1646-1653.
10. 10 Jayaraman, S., Heiligenhaus, A., Rodriguez, A., Soukiasian, S., Dorf, M.E. and Foster, C.S. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells. J. Immunol, 1993, 151, 5777-5789.
11. 11 Kyburz, D., Speiser, D.E., Aebischer, T., Hengartner, H. and Zinkernagel, R.M. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo. J. Immunol. 1993, 150, 5051-5058.
12. 12 Manickan, E., Karem, K.L. and Rouse, B.T. DNA vaccines - a modern gimmick or a boon to vaccinology? Crit. Rev. Immunol. 1997, 17, 139-154.
13. 13 Manickan, E., Rouse, R.J., Yu, Z., Wire, W.S. and Rouse, B.T. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J. Immunol. 1995, 155, 259-265.
14. 14 Martin, S., Moss, B., Berman, P.W., Laskey, L.A. and Rouse, B.T. Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells. J. Virol. 1987, 61, 726-734.
15. 15 Reddy, R., Nair, S., Brynestad, K. and Rouse, B.T. Liposomes as antigen delivery systems in viral immunity. Semin. Immunol. 1992, 4, 91-96.
16. 16 Rothel, J.S., Waterkeyn, J.G. and Strugnell, R.A. et al. Nucleic acid vaccination of sheep: use in combination with a conventional adjuvanted vaccine against Taenia ovis. Immunol. Cell. Biol. 1997, 75, 41-46.
17. 17 Speiser, D.E., Kyburz, D., Stubi, U., Hengartner, H. and Zinkernagel, R.M. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection. J. Immunol. 1992, 149, 972-980.
18. 18 Ulmer, J.B., Donnelly, J.J. and Parker, S.E. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259, 1745-1749.
19. 19 Vasilakos, J.P. and Michael, J.G. Enhancement of CTL response induced by a viral peptide using cationized BSA, a Th1-stimulating adjuvant. Viral Immunol. 1994, 7, 179-188.
20. 20 Wang, B., Ugen, K.E. and Srikantan, V. et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 1993, 90, 4156-4160.
21. 21 Welling, W.S., Scheffer, A.J. and Welling, G.W. B and T cell epitopes of glycoprotein D of herpes simplex virus type 1. FEMS Microbiol. Immunol. 1991, 3, 59-68.